Company Announcement Xbrane to present at Biotech Showcase™ 2020 in San Francisco
Xbrane Biopharma AB (publ.) ('Xbrane' or 'the Company'), today announced that it will be presenting at Biotech Showcase (TM) 2020 in San Francisco, on January 14, during the most important annual gathering for life science investors and strategic partners.
Martin Åmark, CEO, will be presenting Xbrane at Biotech Showcase (TM) as follows:
Date: Tuesday, January 14, 2020
Time: 2:00 p.m. (PST)
Room: Hilton/Yosemite A, Ballroom Level
Venue: Hilton San Francisco Union Square Hotel, 333 O'Farrell Street, San Francisco, CA (United States)
Contacts
Martin Åmark, CEO
M: +46 (0) 763-093 777
E: martin.amark@xbrane.com
Susanna Helgesen, CFO
M: +46 (0) 708-278 636
E: susanna.helgesen@xbrane.com
About Us
Xbrane is a commercial phase Swedish biopharmaceutical company that develop and produces biosimilars. Xbrane has a patented protein production platform for development of biosimilars and world leading expertise in biosimilars. Xbrane's headquarter is located in Solna outside of Stockholm and the company's in-house research and development facilities are in Sweden and Italy. Xbrane is listed at Nasdaq Stockholm since September 2019 with the ticker XBRANE. For more information please visit www.xbrane.com.
Attachments:
Xbrane to present at Biotech Showcase™ 2020 in San Francisco.pdf
Attachments
- Original document
- Permalink
Disclaimer
NASDAQ OMX Nordic - NASDAQ OMX Stockholm AB published this content on 13 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 January 2020 15:02:08 UTC
